Pharmacodynamics of evocalcet for secondary hyperparathyroidism in Japanese hemodialysis patients

Background This study investigated the pharmacokinetics, pharmacodynamics, and safety of multiple doses of evocalcet in Japanese secondary hyperparathyroidism (SHPT) patients receiving hemodialysis.